BioAge Labs (BIOA) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
BioAge Labs is the larger company by market cap ($291.0 million vs $260.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIOA | VOGX |
|---|---|---|
| Share price | $6.34 | $17.56 |
| Market cap | $290.99M | $260.86M |
| 1-day change | +2.09% | +0.40% |
| YTD return | -53.06% | — |
| 1-year return | +9.52% | — |
| EPS (TTM) | $-2.39 | $-0.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.96 | $38.41 |
| 52-week low | $5.04 | $12.95 |
| Distance from 52-week high | -75.57% | -54.28% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +461.99% | +213.21% |
| Average volume | 918.75K | 187.66K |
| Shares outstanding | 45.90M | 14.86M |
| Employees | 60 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About BioAge Labs
BIOA stock →BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging.
Health Care · Biotechnology: Pharmaceutical Preparations · 60 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
BIOA vs VOGX FAQ
Which is bigger, BioAge Labs or Vogenx?
BioAge Labs (BIOA) is larger, with a market capitalization of $290.99M compared with $260.86M for Vogenx (VOGX).
Are BioAge Labs and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.